Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a new version of the page. This update seems administrative and does not affect the study details shown.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. No other content changes.SummaryDifference0.1%

- Check91 days agoChange DetectedA new Revision: v3.4.2 banner was added and an older government funding/operating-status notice (v3.4.1) was removed, as a housekeeping update that does not affect study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange DetectedAdded a government funding lapse notice at the top of the page with guidance to visit cc.nih.gov and opm.gov for updates. Updated site revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.